OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
0 hedge funds and large institutions have $0 invested in OncoSec Medical Incorporated in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
100% less funds holding
Funds holding: 12 → 0 (-12)
100% less capital invested
Capital invested by funds: $665K → $0 (-$665K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$272K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$148K |
| 3 |
State Street
Boston,
Massachusetts
|
-$65K |
| 4 |
SM
Salzhauer Michael
|
-$53.7K |
| 5 |
Bank of New York Mellon
New York
|
-$45K |
ONCS Hedge Fund Activity: Q2 2023 in Review
0 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2023, worth a combined $0 — down 100% from $665K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ONCS and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was FNY Investment Advisers, exiting entirely with an estimated $272K sold.
- 0 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2023, down from 12 in Q1 2023.
- Funds reported $0 of OncoSec Medical Incorporated stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new OncoSec Medical Incorporated positions in Q2 2023 and 12 closed out, a net change of -12 holders.
- The largest OncoSec Medical Incorporated seller in Q2 2023 was FNY Investment Advisers, an estimated $272K sold.
Based on aggregated 13F filings for Q2 2023.